Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Reynolds

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
NPJ Parkinson'S Disease|November 19, 2025
A review of the evidence for a protective role of uric acid in Parkinson's diseaseHanxiang Liu, Gavin P Reynolds
Neuroscience Letters|August 17, 2005
An in vitro model of inflammatory neurodegeneration and its neuroprotectionKirsten Messmer, Gavin P Reynolds
Pharmacogenomics|March 12, 2011
Functional consequences of two HTR2C polymorphisms associated with antipsychotic-induced weight gainMatthew J Hill, Gavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|September 15, 2016
Modelling the cognitive and neuropathological features of schizophrenia with phencyclidineGavin P Reynolds, Joanna C Neill
Epigenomics|February 27, 2016
Does DNA methylation influence the effects of psychiatric drugs?Gavin P Reynolds, Helene A Fachim
Journal of Psychiatric Research|August 6, 2010
Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorderLindsay M Reynolds, Gavin P Reynolds
Pharmacology & Therapeutics|November 26, 2009
Metabolic side effects of antipsychotic drug treatment--pharmacological mechanismsGavin P Reynolds, Shona L Kirk
Journal of Psychopharmacology (Oxford, England)|March 2, 2012
Special issue on PharmacogeneticsKatherine J Aitchison, Gavin P Reynolds
Schizophrenia Research|April 17, 2002
A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophreniaZhi Jun Zhang, Gavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|September 12, 2017
Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatmentGavin P Reynolds, Olga O McGowan
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
NPJ Parkinson'S Disease|November 19, 2025
A review of the evidence for a protective role of uric acid in Parkinson's diseaseHanxiang Liu, Gavin P Reynolds
Neuroscience Letters|August 17, 2005
An in vitro model of inflammatory neurodegeneration and its neuroprotectionKirsten Messmer, Gavin P Reynolds
Pharmacogenomics|March 12, 2011
Functional consequences of two HTR2C polymorphisms associated with antipsychotic-induced weight gainMatthew J Hill, Gavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|September 15, 2016
Modelling the cognitive and neuropathological features of schizophrenia with phencyclidineGavin P Reynolds, Joanna C Neill
Epigenomics|February 27, 2016
Does DNA methylation influence the effects of psychiatric drugs?Gavin P Reynolds, Helene A Fachim
Journal of Psychiatric Research|August 6, 2010
Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorderLindsay M Reynolds, Gavin P Reynolds
Pharmacology & Therapeutics|November 26, 2009
Metabolic side effects of antipsychotic drug treatment--pharmacological mechanismsGavin P Reynolds, Shona L Kirk
Journal of Psychopharmacology (Oxford, England)|March 2, 2012
Special issue on PharmacogeneticsKatherine J Aitchison, Gavin P Reynolds
Schizophrenia Research|April 17, 2002
A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophreniaZhi Jun Zhang, Gavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|September 12, 2017
Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatmentGavin P Reynolds, Olga O McGowan
Pageof 14